According to public data, the number of people with hyperuricemia and gout in China is about 177 million, and the number of gout patients is about 14.66 million, and it is expected to reach 240 million by 2030. Stimulated by huge consumer demand, the market size of gout drugs in mainland China has increased from 900 million yuan in 2016 to 2.8 billion yuan in 2020, and is expected to grow to 10.8 billion yuan in 2030.
As a leader in the medical device industry and in vitro testing industry, Sinocare focuses on patients with hyperuricemia and gout, and for the first time launched the concept of "April Anti-Gout Month", deeply uniting more than 100 chains, 30 tertiary hospitals, and 60 grassroots hospitals to carry out 420 popular science activities, linking online and offline, and continuing to carry out more than 200 uric acid free testing and live broadcast activities for 10,000 people, aiming to enhance the public's awareness of the prevention and control of high uric acid.
Swipe left and right to see more images
01
Sannuo 10,000 people are exempt from testing for public welfare, and strengthen the awareness of high uric acid prevention and control
According to reports, in the "420 Science Popularization Activity", Sinocare Biologics United Pharmaceutical Holding Guoda Pharmacy Shenyang Chain Co., Ltd., Yixintang Pharmaceutical Group Co., Ltd., Guizhou Yipin Pharmaceutical Chain Co., Ltd., Shenzhen Neptunus Yidian Pharmaceutical Co., Ltd., Shuyu Civilian Pharmacy Chain Co., Ltd., Hebei Shenwei Pharmaceutical Group Co., Ltd., Shaanxi Zhongxin Pharmaceutical Chain Co., Ltd., (Quanyi) Suzhou Jianshengyuan Pharmaceutical Chain Co., Ltd., Hegang Jishitang Pharmaceutical Chain Retail Co., Ltd., Guangdong Bangjian Pharmaceutical Chain Co., Ltd. and other chains (in no particular order) have carried out public welfare test-free activities for 10,000 people in dozens of cities across the country, attracting a total of more than 10,000 people to participate.
Swipe left and right to see more photos
During the event, Sinocare Biotech and the chain provided free uric acid, blood sugar and blood pressure testing services for the general public, and provided them with health guidance in various aspects such as healthy diet, scientific prevention and treatment, and later medication according to the test results, so as to help them enhance their awareness of prevention and health management capabilities.
Swipe left and right to see more photos
In addition to professional testing, Sinocare has also set up a game interactive area with the chain to experience gout roadshow activities for free, attracting more citizens to participate in the entertainment and education, and deepening consumers' understanding of the dangers of hyperuricemia and gout.
Swipe left and right to see more images
02
The online live broadcast of high uric acid popularized science, and the number of viewers exceeded 100,000
In order to expand the public's awareness of hyperuricemia, Sinocare cooperated with more than 10 chains to jointly carry out large-scale online live broadcast activities, and invited medical experts to the live broadcast site to explain the dangers and prevention methods of hyperuricemia online, the importance of home self-testing of uric acid, and the precautions in the daily life of gout patients, with a total of more than 100,000 viewers.
(Disclaimer: This screen is only an example, regardless of ranking)
It is worth mentioning that in this online + offline "420 popular science activity", Sinocare Biotech launched a 5% discount on uric acid meter, and synchronized with Tmall Jingdong Taobao, so that consumers in need can spend the least amount of money to experience the 10-second value of the quasi-uric acid meter without adjusting the code.
03
Innovate the health management of chronic diseases and contribute to the construction of a healthy China
On the occasion of the Anti-Gout Month in April, Sinocare Biotech co-planned the "420 Science Popularization Activity" with brand chains, hospitals and communities, which is an important manifestation of the company's accurate capture of consumer needs, giving back to patients with chronic diseases such as hyperuricemia and gout with accurate, simple and affordable products, and actively assuming the responsibility and responsibility of "improving the health level of the whole people", and it is also an important innovation for Sinocare to actively empower the new growth of chain channels!
At the same time, Sinocare has also obtained real feedback from consumers on products through this "420 Science Popularization Activity", and has a comprehensive insight into consumer needs and pain points, and will give back to consumers with better products in the future, and continue to build new competitiveness.
In the future, Sinocare will continue to take "providing innovative and high-quality products and services for people with diabetes and related chronic diseases around the world to help them improve their quality of life", continue to carry out technological innovation and product innovation, improve the convenience and accuracy of products, improve the efficiency and quality of health monitoring and disease management, and cooperate with more chains to continue to provide high-quality health services for the general public, jointly promote the development of national health, and contribute to the construction of a healthy China.
END